MedPath
NMPA Approval

Losartan Potassium Tablets

H20140913

April 7, 2020

H20140913

Drug Information

氯沙坦钾片

片剂

50mg

化学药品

April 7, 2020

April 6, 2025

Company Information

Applicant Company

Sandoz Gmbh

Biochemiestra β e 10, 6250 Kundl, Austria

Manufacturing Company

novartis pharmaceutical manufacturing llc

Verovskova ulica 57, Ljubljana, 1000, Slovenia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氯沙坦钾片 - NMPA 批准文号 | MedPath